Prevention of Surgery-Induced Dry Eye by Diquafosol Eyedrops after Femtosecond Laser-Assisted Cataract Surgery
Abstract
:1. Introduction
2. Patients and Methods
3. Statistical Analysis
4. Results
5. Discussion
6. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
References
- DEWS. The definition and classification of dry eye disease: Report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul. Surf. 2007, 5, 75–92. [Google Scholar] [CrossRef]
- Keating, G.M. Diquafosol Ophthalmic Solution 3%: A Review of Its Use in Dry Eye. Drugs 2015, 75, 911–922. [Google Scholar] [CrossRef] [PubMed]
- Pendergast, W.; Yerxa, B.R.; Douglass, J.G.; Shaver, S.R.; Dougherty, R.W.; Redick, C.C.; Sims, I.F.; Rideout, J.L. Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5′-polyphosphates. Bioorganic Med. Chem. Lett. 2001, 11, 157–160. [Google Scholar] [CrossRef]
- Cowlen, M.S.; Zhang, V.Z.; Warnock, L.; Moyer, C.F.; Peterson, W.M.; Yerxa, B.R. Localization of ocular P2Y2 receptor gene expression by in situ hybridization. Exp. Eye Res. 2003, 77, 77–84. [Google Scholar] [CrossRef]
- Fujihara, T.; Murakami, T.; Nagano, T.; Nakamura, M.; Nakata, K. INS365 Suppresses Loss of Corneal Epithelial Integrity by Secretion of Mucin-like Glycoprotein in a Rabbit Short-term Dry Eye Model. J. Ocul. Pharmacol. Ther. 2002, 18, 363–370. [Google Scholar] [CrossRef]
- Li, Y.; Kuang, K.; Yerxa, B.; Wen, Q.; Rosskothen, H.; Fischbarg, J. Rabbit conjunctival epithelium transports fluid, and P2Y22 receptor agonists stimulate Cl− and fluid secretion. Am. J. Physiol. Physiol. 2001, 281, C595–C602. [Google Scholar] [CrossRef]
- Murakami, T.; Fujihara, T.; Horibe, Y.; Nakamura, M. Diquafosol Elicits Increases in Net Cl– Transport through P2Y2 Receptor Stimulation in Rabbit Conjunctiva. Ophthalmic Res. 2004, 36, 89–93. [Google Scholar] [CrossRef]
- Takamura, E.; Tsubota, K.; Watanabe, H.; Ohashi, Y.; for The Diquafosol Ophthalmic Solution Phase 3 Study Group. A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients. Br. J. Ophthalmol. 2012, 96, 1310–1315. [Google Scholar] [CrossRef]
- Fujihara, T.; Murakami, T.; Fujita, H.; Nakamura, M.; Nakata, K. Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model. Investig. Ophthalmol. Vis. Sci. 2001, 42, 96–100. [Google Scholar]
- Kojima, T.; Dogru, M.; Ibrahim, O.M.; Nagata, T.; Higa, K.; Shimizu, T.; Shirasawa, T.; Satake, Y.; Shimazaki, S.; Shimazaki, J.; et al. The effects of 3% diquafosol sodium application on the tear functions and ocular surface of the Cu,Zn-superoxide dismutase-1 (Sod1)–knockout mice. Mol. Vis. 2014, 20, 929–938. [Google Scholar]
- Yokoi, N.; Kato, H.; Kinoshita, S. Facilitation of Tear Fluid Secretion by 3% Diquafosol Ophthalmic Solution in Normal Human Eyes. Am. J. Ophthalmol. 2014, 157, 85–92.e1. [Google Scholar] [CrossRef] [PubMed]
- Jumblatt, J.E.; Jumblatt, M.M. Regulation of Ocular Mucin Secretion by P2Y2Nucleotide Receptors in Rabbit and Human Conjunctiva. Exp. Eye Res. 1998, 67, 341–346. [Google Scholar] [CrossRef]
- Matsumoto, Y.; Ohashi, Y.; Watanabe, H.; Tsubota, K.; Diquafosol Ophthalmic Solution Phase 2 Study Group. Efficacy and Safety of Diquafosol Ophthalmic Solution in Patients with Dry Eye Syndrome: A Japanese Phase 2 Clinical Trial. Ophthalmology 2012, 119, 1954–1960. [Google Scholar] [CrossRef] [PubMed]
- Baek, J.; Doh, S.H.; Chung, S.K. The Effect of Topical Diquafosol Tetrasodium 3% on Dry Eye After Cataract Surgery. Curr. Eye Res. 2016, 41, 1281–1285. [Google Scholar] [CrossRef]
- Park, D.H.; Chung, J.K.; Seo, D.R.; Lee, S.J. Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial. Am. J. Ophthalmol. 2016, 163, 122–131.e2. [Google Scholar] [CrossRef] [PubMed]
- Miyake, K.; Yokoi, N. Influence on ocular surface after cataract surgery and effect of topical diquafosol on postoperative dry eye: A multicenter prospective randomized study. Clin. Ophthalmol. 2017, 11, 529–540. [Google Scholar] [CrossRef] [PubMed]
- Jun, I.; Choi, S.; Lee, G.Y.; Choi, Y.J.; Lee, H.K.; Kim, E.K.; Seo, K.Y.; Kim, T.-I. Effects of Preservative-free 3% Diquafosol in Patients with Pre-existing Dry Eye Disease after Cataract Surgery: A Randomized Clinical Trial. Sci. Rep. 2019, 9, 12659. [Google Scholar] [CrossRef]
- Kasetsuwan, N.; Satitpitakul, V.; Changul, T.; Jariyakosol, S. Incidence and Pattern of Dry Eye after Cataract Surgery. PLoS ONE 2013, 8, e78657. [Google Scholar] [CrossRef]
- Li, X.-M.; Hu, L.; Hu, J.; Wang, W. Investigation of Dry Eye Disease and Analysis of the Pathogenic Factors in Patients after Cataract Surgery. Cornea 2007, 26, S16–S20. [Google Scholar] [CrossRef]
- Ram, J.; Gupta, A.; Brar, G.S.; Kaushik, S.; Gupta, A. Outcomes of phacoemulsification in patients with dry eye. J. Cataract Refract. Surg. 2002, 28, 1386–1389. [Google Scholar] [CrossRef]
- Han, K.E.; Yoon, S.C.; Ahn, J.M.; Nam, S.M.; Stulting, R.D.; Kim, E.K.; Seo, K.Y. Evaluation of Dry Eye and Meibomian Gland Dysfunction After Cataract Surgery. Am. J. Ophthalmol. 2014, 157, 1144–1150.e1. [Google Scholar] [CrossRef] [PubMed]
- Park, Y.; Bin Hwang, H.; Kim, H.S. Observation of Influence of Cataract Surgery on the Ocular Surface. PLoS ONE 2016, 11, e0152460. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gibbons, A.; Ali, T.K.; Waren, D.P.; Donaldson, K.E. Causes and correction of dissatisfaction after implantation of presbyopia-correcting intraocular lenses. Clin. Ophthalmol. 2016, 10, 1965–1970. [Google Scholar] [CrossRef] [PubMed]
- Shao, D.; Zhu, X.; Sun, W.; Cheng, P.; Chen, W.; Wang, H. Effects of femtosecond laser-assisted cataract surgery on dry eye. Exp. Ther. Med. 2018, 16, 5073–5078. [Google Scholar] [CrossRef] [PubMed]
- Yu, Y.; Hua, H.; Wu, M.; Yu, Y.; Yu, W.; Lai, K.; Yao, K. Evaluation of dry eye after femtosecond laser–assisted cataract surgery. J. Cataract Refract. Surg. 2015, 41, 2614–2623. [Google Scholar] [CrossRef]
- Kato, K.; Miyake, K.; Kondo, N.; Asano, S.; Takeda, J.; Takahashi, A.; Takashima, Y.; Kondo, M. Conjunctival Goblet Cell Density Following Cataract Surgery With Diclofenac Versus Diclofenac and Rebamipide: A Randomized Trial. Am. J. Ophthalmol. 2017, 181, 26–36. [Google Scholar] [CrossRef]
- Donnenfeld, E.D.; Solomon, R.; Roberts, C.W.; Wittpenn, J.R.; McDonald, M.B.; Perry, H.D. Cyclosporine 0.05% to improve visual outcomes after multifocal intraocular lens implantation. J. Cataract Refract. Surg. 2010, 36, 1095–1100. [Google Scholar] [CrossRef]
- Rodriguez-Prats, J.L.; Hamdi, I.; Rodriguez, A.E.; Galal, A.; Alio, J.L. Effect of Suction Ring Application During LASIK on Goblet Cell Density. J. Refract. Surg. 2007, 23, 559–562. [Google Scholar] [CrossRef]
- Salomão, M.Q.; Ambrósio, R.; Wilson, S.E. Dry eye associated with laser in situ keratomileusis: Mechanical microkeratome versus femtosecond laser. J. Cataract Refract. Surg. 2009, 35, 1756–1760. [Google Scholar] [CrossRef]
- Ju, R.-H.; Chen, Y.; Chen, H.-S.; Zhou, W.-J.; Yang, W.; Lin, Z.-D.; Wu, Z.-M. Changes in ocular surface status and dry eye symptoms following femtosecond laser-assisted cataract surgery. Int. J. Ophthalmol. 2019, 12, 1122–1126. [Google Scholar] [CrossRef]
- Inoue, Y.; Ochi, S. Effects of 3% diquafosol sodium ophthalmic solution on higher-order aberrations in patients diagnosed with dry eye after cataract surgery. Clin. Ophthalmol. 2016, 11, 87–93. [Google Scholar] [CrossRef] [PubMed]
- Cui, L.; Li, Y.; Lee, H.S.; Yang, J.M.; Choi, W.; Yoon, K.C. Effect of diquafosol tetrasodium 3% on the conjunctival surface and clinical findings after cataract surgery in patients with dry eye. Int. Ophthalmol. 2017, 38, 2021–2030. [Google Scholar] [CrossRef] [PubMed]
- Teshigawara, T.; Meguro, A.; Mizuki, N. The Effect of Rebamipide on Refractive Accuracy of Cataract Surgery in Patients with Dry Eye. Ophthalmol. Ther. 2022, 11, 603–611. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Yamazaki, K.; Yoneyama, J.; Kimoto, R.; Shibata, Y.; Mimura, T. Prevention of Surgery-Induced Dry Eye by Diquafosol Eyedrops after Femtosecond Laser-Assisted Cataract Surgery. J. Clin. Med. 2022, 11, 5757. https://doi.org/10.3390/jcm11195757
Yamazaki K, Yoneyama J, Kimoto R, Shibata Y, Mimura T. Prevention of Surgery-Induced Dry Eye by Diquafosol Eyedrops after Femtosecond Laser-Assisted Cataract Surgery. Journal of Clinical Medicine. 2022; 11(19):5757. https://doi.org/10.3390/jcm11195757
Chicago/Turabian StyleYamazaki, Kenichiro, Junko Yoneyama, Ryuta Kimoto, Yuko Shibata, and Tatsuya Mimura. 2022. "Prevention of Surgery-Induced Dry Eye by Diquafosol Eyedrops after Femtosecond Laser-Assisted Cataract Surgery" Journal of Clinical Medicine 11, no. 19: 5757. https://doi.org/10.3390/jcm11195757